Evangelos Terpos to Proteasome Inhibitors
This is a "connection" page, showing publications Evangelos Terpos has written about Proteasome Inhibitors.
Connection Strength
0.230
-
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells. J Cell Mol Med. 2019 12; 23(12):8010-8018.
Score: 0.188
-
Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events. Sci Rep. 2017 12 19; 7(1):17802.
Score: 0.042